XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Free Cash Flow (2022 - 2023)

Updated

XORTX Therapeutics (XRTX) recorded Free Cash Flow of -$2.77 million in the year ended Dec 31, 2025, compared with -$3.68 million a year earlier.

Analysis

XORTX Therapeutics (XRTX) Free Cash Flow (2022 - 2023) Analysis & Trends

Starting with the year ended Dec 31, 2019, XORTX Therapeutics' Free Cash Flow history includes 7 years.

  • The figure for the year ended Dec 31, 2025 is the highest annual Free Cash Flow since the year ended Dec 31, 2021.
  • Per Business Quant data, XRTX's Free Cash Flow was -$3.68 million in the year ended Dec 31, 2024, -$6.58 million in the year ended Dec 31, 2023, -$9.19 million in the year ended Dec 31, 2022 and $4.84 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.00
Jun 30, 2023 1,637.00
Mar 31, 2023 2,673.00
Dec 31, 2022 -3.80 Mn
Sep 30, 2022 -951,091.21
API Access

XORTX Therapeutics Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=XRTX&period=max&api_key=YOUR_API_KEY